The benign and malignant diseases of pancreas and pars ampullaris
Conditions
Interventions
external pancreatic duct drainage group:pancreatic duct stent is placed outside the body
proximal internal pancreatic duct drainage group:pancreatic duct stent is placed 7-8cm from the pancreatico-jejunal anastomotic stoma in the intestine
distal internal pancreatic duct drainage group:pancreatic duct stent is placed 50-55cm from the pancreatico-jejunal anastomotic stoma in the intestine
Sponsors
Department of Pancreatic and Biliary Surgery, The First Affiliated Hospital of Harbin Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: The patients who are ready to undergo pancreaticoduodenectomy because of the benign and malignant diseases of pancreas and pars ampullaris aged 18-80 years old.
Exclusion criteria
Exclusion criteria: 1. the patient or family refuses to enroll; 2. emergent pancreaticoduodenectomy; 3. a history of abdominal surgery; 4. a history of serious cardiac,pulmonary and renal dysfunction; 5. severe liver cirrhosis, mental disorder or hemodialysis; 6. the tumors can not be resected after exploratory laparotomy; 7. total pancreaticoduodenectomy; 8. receive preoperative neoadjuvant chemotherapy; 9. the pancreatic duct can not be found during the operation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| incidence of postoperative pancreatic fistula;postoperative pancreatic fistula healing time; | — |
Secondary
| Measure | Time frame |
|---|---|
| incidence of postoperative related complications;incidence of global postoperative complications;intraoperative blood loss;surgical duration;duration of postoperative hospitalization;perioperative mortality;reoperation rat; | — |
Contacts
Public ContactSun Bei
Department of Pancreatic and Biliary Surgery, The First Affiliated Hospital of Harbin Medical University
Outcome results
None listed